The majority of patients do not store their biologic disease-modifying antirheumatic drugs within the recommended temperature range-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The majority of patients do not store their biologic disease-modifying antirheumatic drugs within the recommended temperature range

Published:2015-12-16 Issue:4 Volume:55 Page:704-709
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Vlieland Nicolaas D.,Gardarsdottir Helga,Bouvy Marcel L.,Egberts Toine C. G.,van den Bemt Bart J. F.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/55/4/704/17389390/kev394.pdf

Reference34 articles.

1. Irresistible force meets immoveable object

2. Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study

3. The Canadian Methotrexate and Etanercept Outcome Study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis

4. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial

5. Continuation of Methotrexate Resulted in Better Clinical and Radiographic Outcomes Than Discontinuation upon Starting Etanercept in Patients with Rheumatoid Arthritis: 52-week Results from the JESMR Study

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Post Manufacturing Handling of Protein-Based Biologic Drugs on Product Quality and User Centricity;Journal of Pharmaceutical Sciences;2024-08

2. Filgrastim biosimilar (EP2006): A review of 15 years’ post-approval evidence;Critical Reviews in Oncology/Hematology;2024-04

3. Effect of a smart temperature logger on correctly storing biological disease-modifying antirheumatic drugs at home: a pre-post study;European Journal of Hospital Pharmacy;2024-02-21

4. Formulation of Biologics Including Biopharmaceutical Considerations;Pharmaceutical Biotechnology;2024

5. Stability analysis of monoclonal antibodies;Therapeutic Monoclonal Antibodies - From Lot Release to Stability Testing;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3